| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.39▲ | 2.39▲ | 2.38▲ | 2.44▼ | 2.69▼ |
| MA10 | 2.39▲ | 2.37▲ | 2.37▲ | 2.55▼ | 3.24▼ |
| MA20 | 2.39▲ | 2.38▲ | 2.40▼ | 2.85▼ | 3.65▼ |
| MA50 | 2.36▲ | 2.44▼ | 2.57▼ | 3.46▼ | 4.85▼ |
| MA100 | 2.37▲ | 2.57▼ | 2.66▼ | 3.77▼ | 4.44▼ |
| MA200 | 2.40▼ | 2.71▼ | 3.14▼ | 4.69▼ | 3.50▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▼ | 0.010▲ | 0.010▲ | -0.018▼ | -0.132▼ |
| RSI | 60.685▲ | 49.554▼ | 41.743▼ | 25.848▼ | 26.430▼ |
| STOCH | 75.000 | 89.444▲ | 47.937 | 12.971▼ | 7.374▼ |
| WILL %R | 0.000▲ | 0.000▲ | -41.176 | -90.050▼ | -94.751▼ |
| CCI | 97.552 | 107.173▲ | 31.755 | -129.962▼ | -147.032▼ |
|
Thursday, October 15, 2026 01:00 AM
Company remains on track to report interim results from Phase 2b cohort in 4Q 2026 NEW YORK, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage biotechnology ...
|
|
Tuesday, May 19, 2026 05:00 PM
Oppenheimer analyst Leland Gershell maintains Protara Therapeutics (NASDAQ:TARA) with a Outperform and raises the price target from $25 to $28. JP Morgan analyst Brian Cheng maintains Protara ...
|
|
Tuesday, February 24, 2026 07:23 AM
Protara Therapeutics (NASDAQ:TARA) on February 23, 2026, announced updated interim data from its ongoing Phase 2 ADVANCED-2 trial evaluating intravesical TARA-002 in patients with high-risk non-muscle ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 19/10/26 | 2.375 | 2.395 | 2.295 | 2.395 | 831,444 |
| 16/10/26 | 2.38 | 2.465 | 2.32 | 2.32 | 1,152,955 |
| 15/10/26 | 2.51 | 2.5578 | 2.375 | 2.40 | 861,569 |
| 14/10/26 | 2.60 | 2.6589 | 2.47 | 2.48 | 701,413 |
| 13/10/26 | 2.77 | 2.83 | 2.615 | 2.62 | 930,189 |
| 12/10/26 | 2.75 | 2.79 | 2.705 | 2.77 | 1,080,595 |
| 09/10/26 | 2.69 | 2.785 | 2.65 | 2.755 | 1,037,307 |
| 08/10/26 | 2.59 | 2.69 | 2.515 | 2.65 | 1,214,128 |
| 07/10/26 | 2.54 | 2.67 | 2.51 | 2.59 | 731,349 |
| 06/10/26 | 2.63 | 2.70 | 2.53 | 2.555 | 800,857 |
|
|
||||
|
|
||||
|
|